04 August 2022

Portfolio insights

Company in focus: EUSA Pharma

Video thumbnail of Erik Wong - discussing EUSA Pharma

EUSA Pharma, a global, specialty in-licensing pharmaceutical company focused on oncology and rare diseases, is PIN’s largest ever single company exit after it was sold in December 2021.